Patent · US Active

Cytotoxic peptides and antibody drug conjugates thereof

US8828401B2 · kind B2 · utility

8Cited by
16References
36Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 7, 2012
Grant dateSep 9, 2014
Priority date
Expiry dateNov 7, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is directed to cytotoxic pentapeptides, to antibody drug conjugates thereof, and to methods for using the same to treat cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.